AGPU
Axe Compute Inc.
$6.78
-0.61 (-8.25%)
At close · Jul 8
Market Cap
$70.54M
Shares
10,404,641
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$125.28K
+47.7%
FY2025
Net Income
-$233.1M
-1740.6%
FY2025
Gross Margin
940.53%
+878pp
FY2024
Operating Margin
-144404.49%
-132255.4pp
FY2025
Operating Cash Flow
-$9.88M
+2.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 | FY2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $35.31K | $125.28K | $84.81K | $1.63M | $1.51M | $1.42M | $1.25M | $1.41M | $1.41M | $654.84K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $6770 | $72.62K | $78.29K | $609.21K | $505.11K | $487.02K | $447.19K | $531.81K | $415.76K | $148.05K | $181.62K | $303.98K | $385.32K | $189.71K | $128.54K | $56.08K | $140 | — | — | — | — | — | — | — | — | |
| $814.04K | — | $797.68K | $1.02M | $1M | $933.66K | $805.08K | $879.76K | $995.89K | $506.79K | $274.88K | $350.37K | $566.24K | $278.42K | $60.23K | $40.56K | $148 | — | — | — | — | — | — | — | — | |
| — | — | 940.53% | 62.57% | 66.45% | 65.72% | 64.29% | 62.32% | 70.55% | 77.39% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $2.15M | $2.24M | $122.31K | $320.32K | $315.85K | $372.71K | $422.96K | $526.26K | $289K | $406K | $261K | $394K | $235K | $15K | $0 | — | $100K | — | — | — | — | — | — | — | |
| $8387 | $406.25K | $833.2K | $1.49M | $1.36M | $774.53K | $584.94K | $1.91M | $2.37M | $1.1M | $467.97K | $503.99K | $1.18M | $578.79K | $172.97K | $232.72K | $199.59K | — | — | — | — | — | — | — | — | |
| $2.91M | $25.92M | $7.24M | $8.38M | $11.11M | $10.93M | $10.35M | $9.78M | $4.63M | $4.05M | $5.17M | $3.4M | $4.88M | $7.53M | $6.29M | $3.56M | $1.87M | — | — | — | — | — | — | — | — | |
| $26.18K | — | $26.49K | $26.46K | $414.71K | $374.33K | $313.71K | $290.55K | $62.63K | $12.69K | $9107 | $6291 | $140.59K | $140.59K | — | — | — | — | — | — | — | — | — | — | — | |
| — | $129.04K | $132.34K | $244.79K | $1.31M | $1.34M | $1.02M | $704.88K | $147.63K | $71.56K | $82.36K | $78.57K | $63.04K | — | — | — | — | — | — | — | — | — | — | — | — | |
| $11.77M | — | $11.74M | $13.14M | $27.03M | — | — | — | $7.86M | $6.05M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $28.55M | $10.39M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$7.73M | -$180.92M | -$10.3M | -$12.12M | -$26.03M | -$20.43M | -$25.36M | -$22.64M | -$7.86M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -144404.49% | -12149.14% | -744.47% | -1729.28% | -1437.95% | -2025.12% | -1604.23% | -556.89% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$180.79M | -$10.17M | -$11.87M | -$24.72M | -$19.09M | -$24.34M | -$21.94M | -$7.71M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | $3 | $390.89K | $377.72K | $636.5K | $259.35K | $230.37K | $147.09K | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | -$439.64K | -$2.29M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | -$25.74M | -$20.32M | -$25.88M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $0 | $0 | $0 | $0 | -$661.66K | $0 | $0 | — | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$238.36M | -$233.1M | -$12.66M | -$13.98M | -$25.74M | -$19.66M | -$25.88M | -$19.39M | -$10.09M | — | — | — | -$6.83M | -$9.41M | -$7.42M | -$4.49M | — | — | — | — | — | — | — | — | — | |
| — | -186053.45% | -14932.31% | -859.13% | -1709.62% | -1383.65% | -2066.99% | -1373.71% | -714.51% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| -$238.36M | -$233.1M | -$12.66M | -$13.98M | -$25.74M | -$19.66M | -$26.44M | -$19.68M | -$10.09M | -$6M | -$6.53M | -$4.79M | -$6.83M | -$9.41M | -$7.42M | -$4.49M | -$1.35M | -$2.89M | -$1.76M | -$752.42K | -$273.03K | -$123.85K | -$90.35K | -$90.46K | -$51.06K | |
| — | — | — | — | — | — | — | — | — | -$7.75M | -$6.52M | -$4.79M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$13.37 | -$34.83 | -$52.20 | -$104.70 | -$108.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 17.43M | 363.58K | 267.66K | 245.73K | 182.92K | 39.83K | 9567.1067 | 4272.0967 | 21.21K | 9411.15 | 517.4433 | 9968.2367 | 6753.7167 | 231.96K | 80.94K | — | — | — | — | — | — | — | — | — |
| shares | — | 17.43M | 363.58K | 267.66K | 245.73K | 182.92K | 39.83K | 9567.1067 | 4272.0967 | 21.21K | 9411.15 | 12.94K | 9968.2367 | 63.18K | 231.96K | 80.94K | — | — | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2024: $40.69K in buybacks.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Drug Discovery Services Segment | $84,812 | — | — | — | — |
| Compute Services and Treasury Management Segment | $0 | — | — | — | — |
| Birmingham | — | — | $82,301 | — | — |
| Eagan | — | $1,135,101 | $1,063,493 | — | — |
| Helomics Segment | — | — | — | $13,367 | $64,188 |
| Pittsburgh | — | $492,596 | $358,776 | — | — |
| Skyline | — | — | — | $1,169,811 | $1,185,214 |
| Soluble | — | — | — | $233,293 | $2,870 |
| ZPREDICTA | — | — | — | $90 | — |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Compute Services and Treasury Management Segment | $0 | — |
| Eagan | -$635,541 | -$968,379 |
| Drug Discovery Services Segment | -$4,250,711 | — |
| Pittsburgh | -$4,250,711 | -$4,510,763 |
Operating Margin by Segment (%)
| Component | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Drug Discovery Services Segment | -5011.9% | — |
| Eagan | — | -85.3% |
| Pittsburgh | — | -915.7% |